Clusterin deficiency exacerbates hyperoxia‐induced acute lung injury

Abstract

Exposure to high oxygen concentrations leads to generation of excessive reactive oxygen species, causing cellular injury and multiple organ dysfunctions and is associated with a high mortality rate. Clusterin (CLU) is a heterodimeric glycoprotein that mediates several intracellular signaling pathways, including cell death and inflammation. However, the role of CLU in the patho-genesis of hyperoxic acute lung injury (HALI) is unknown. Wild‐type (WT) and CLU‐deficient mice and cultured human airway epithelial cells were used. Changes in cell death‐ and inflammation-related molecules with or without hyperoxia exposure in cells and animals were determined. Hy-peroxia induced an increase in CLU expression in mouse lungs and human airway epithelial cells. Mice lacking CLU had increased HALI and mortality rate compared with WT mice. In vitro, CLU-disrupted cells showed enhanced release of cytochrome c, Bax translocation, cell death and inflammatory cytokine expression. However, treatment with recombinant CLU attenuated hyperoxia‐in-duced apoptosis. Moreover, the Kyoto Encyclopedia of Genes and Genomes and Gene Ontology analyses revealed metabolic pathways, hematopoietic cell lineage, response to stress and localization and regulation of immune system that were differentially regulated between WT and CLU−/− mice. These results demonstrate that prolonged hyperoxia‐induced lung injury is associated with CLU expression and that CLU replenishment may alleviate hyperoxia‐induced cell death.